Dr. Christopher Flowers, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Stanford University

  Medical School, 1997

• Patterns of Use and Survival Outcomes of Positron Emission Tomography for Initial Staging in Elderly Follicular Lymphoma Patients, 2016-11-10

• Evolving Landscape of Early Drug Development in Solid Tumors: Analysis of National Cancer Institute Sponsored Phase 1 Trials, 2022-08-13

• Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma, 2017-10-25

• Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era, 2021-08-10

• SARS-CoV-2 in multiple myeloma: initial observation and management, 2020-06-17

• The impact of cell-of-origin, MYC/Bcl-2 Dual Expression andMYCRearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy, 2021-01-22

• Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma, 2023-10-12

• Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma, 2015-12-15

• Insurance status impacts overall survival in Burkitt lymphoma, 2019-07-05

• Re: Treatment decisions and outcome in very elderly patients with diffuse large B-cell lymphoma, 2015-06-25

• The genetic landscape of mutations in Burkitt lymphoma, 2012-11-11

• Impact of Conditioning Chemotherapy on Lymphocyte Kinetics and Outcomes in LBCL Patients Treated with CAR T-cell Therapy, 2022-09-20

• The genetic landscape of immune-competent and HIV lymphoma, 2012-04-19

• Comparing the cost-effectiveness of rituximab maintenance and radio-immunotherapy consolidation versus observation following first-line therapy in follicular lymphoma patients, 2015-02-21

• Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase 2 Study and CIBMTR Outcomes, 2016-03-31

• Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility, 2017-08-10

• Clinical, Molecular, and Environmental Risk Factors for Hodgkin Lymphoma, 2010-11-29

• Resolving uncertainty in the spatial relationships between passive benzene exposure and risk of non-Hodgkin lymphoma, 2016-03-02

• [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice, 2016-08-12

• Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation, 2014-03-06

• A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma, 2021-08-26

• Next-generation surveillance strategies for patients with lymphoma, 2015-07-24

• Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States, 2016-05-24

• Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells, 2023-07-18

• BAYESIAN HIERARCHICAL RANDOM-EFFECTS META-ANALYSIS AND DESIGN OF PHASE I CLINICAL TRIALS, 2022-09-26

• Incidence and outcomes of lymphoid malignancies in adolescent and young adult (AYA) patients in the United States, 2018-08-10

• CondiS: A conditional survival distribution-based method for censored data imputation overcoming the hurdle in machine learning-based survival analysis, 2022-06-09

• Perceptions of Clinical Care and Research Among African-American Patients with Lymphoma, 2021-02-28

• Metastatic Colorectal Cancer: A systematic review of the value of current therapies, 2015-10-22

• Predictors of Local Recurrence After Rituximab Based Chemotherapy Alone in Stage III/IV DLBCL: Guiding Decisions for Consolidative Radiation, 2015-05-01

• Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma, 2019-09-12

• Impact of treatment and insurance on socioeconomic disparities in survival after adolescent and young adult Hodgkin lymphoma: A population-based study, 2016-01-29

• SETD2 haploinsufficiency enhances germinal center-associated AICDA somatic hypermutation to drive B cell lymphomagenesis, 2022-07-06

• Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia, 2017-04-07

• Microsimulation Modeling in Oncology, 2019-02-19

• Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma, 2017-10-05

• B-cell non-Hodgkin lymphoma (NHL) subtype risk associated with autoimmune conditions and polygenic risk scores (PRS), 2022-05-04

• A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients with Previously Untreated Indolent non-Hodgkin's Lymphoma, 2015-08-07

• A Population-Based Multistate Model for Diffuse Large B-Cell Lymphoma-Specific Mortality in Older Patients, 2019-02-01

• The Association of Physical Activity Before and After Lymphoma Diagnosis with Survival Outcomes, 2018-10-17

• The Genetic Basis of Hepatosplenic T Cell Lymphoma, 2017-01-25

• Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States, 2015-04-07

• Genome-Defined African Ancestry is Associated with Distinct Mutations and Worse Survival in Diffuse Large B-Cell Lymphoma, 2020-05-29

• GIFT4 fusokine converts leukemic B cells into immune helper cells, 2016-04-27

• Body mass index and survival of patients with lymphoma, 2021-06-14

• Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia Between India and the United States, 2020-07-21

• Disease Characteristics, Patterns of Care, and Survival in Very Elderly Patients with Diffuse Large B-Cell Lymphoma, 2015-02-11

• Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival, 2021-06-17

• Targeting the B cell receptor pathway in non-Hodgkin lymphoma, 2018-06-07

• Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors, 2018-04-13

• PD-L1+macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma, 2023-03-20

• ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II, 2020-08-10

• Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma Using a Modern Dual-Field Rotational Technique, 2015-02-07

• Incidence Patterns and Outcomes for Hodgkin Lymphoma Patients in the United States, 2010-12-16

• Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era, 2017-05-25

• Impact of post-transplant lymphoproliferative disorder subtype on survival, 2018-03-26

• Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs, 2019-06-04

• ACR Appropriateness Criteria®Recurrent Hodgkin Lymphoma Expert Panel on Radiation Oncology-Hodgkin Lymphoma:, 2016-12-15

• Next-generation prognostic assessment for diffuse large B-cell lymphoma, 2015-08-20

• A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma, 2011-06-16

• Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in CALGB 50401 (Alliance), 2020-08-22

• Disparities in the early adoption of chemo-immunotherapy for diffuse large B-cell lymphoma in the United States, 2012-07-06

• Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population, 2009-01-13

• Prescription Opioid Usage and Abuse Relationships: An Evaluation of State Prescription Drug Monitoring Program Efficacy, 2009-05-01

• Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future, 2012-04-19